Humanity Protocol vs Injective — how do they compare? Humanity Protocol trades at Rp1,044 (market cap Rp3,27T, Rp181,56M 24h volume), while Injective trades at Rp93,269 (market cap Rp9,26T, Rp1,73T 24h volume). The key difference: Injective is far larger — about 2.8× Humanity Protocol's market cap, and Humanity Protocol's supply is capped (3,1B / 10B H (31%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Humanity Protocol for 5 Days and Injective for 36 Days on average.
| H | INJ | |
|---|---|---|
Market Cap | Rp3,27T | Rp9,26T |
Volume (24h) | Rp181,56M | Rp1,73T |
Circulating Supply | 3,1B / 10B H (31%) | 100M INJ |
Typical Hold Time | 5 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Humanity Protocol (H) is currently trading at Rp1,024.62 with a market cap of Rp3.25 trillion, showing bearish technical signals amid neutral oscillators. The token has a circulating supply of 3.1 million out of 10 million max supply (31% circulation rate), with an average hold time of 5 days. Recent technical analysis indicates selling pressure outweighs buying signals, though key indicators like RSI remain neutral, suggesting potential consolidation near current levels.
Overall outlook remains cautious with bearish momentum dominating. Key opportunities include potential bounce from support levels if buying interest returns, while major risks include continued selling pressure and low liquidity depth. Investors should monitor RSI levels and trading volume for trend confirmation, with regulatory uncertainty adding to volatility concerns in the crypto space.
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Humanity Protocol offers a decentralized alternative to government-run biometric ID systems, giving individuals control over their biometric and identity data through secure blockchain technology. This ensures privacy and protection against censorship. It functions as an open identity graph that supports verifiable credentials for attributes like personally identifiable information (PII), education, employment, and event participation. Users can selectively prove different aspects of their identity while maintaining privacy.
Read more on H →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →